Budesonide Clickhaler (budesonide dry-powder inhaler) / Viatris - LARVOL DELTA

Budenoside aqueous nasal spray: an updated review in managing chronic rhinosinusitis with nasal polyps. (PubMed, Panminerva Med) - "In addition, BANS may adequately integrate surgery and biologics for CRSwNP management. In conclusion, BANS represents a valuable option in managing patients with type 2-mediated CRSwNP."

Journal • Review • Allergic Rhinitis • Chronic Rhinosinusitis With Nasal Polyps • Immunology • Inflammation • Nasal Polyps • Otorhinolaryngology • Respiratory Diseases • Sinusitis

Budenoside aqueous nasal spray: an updated reappraisal in rhinitis management. (PubMed, Minerva Med) - "BANS could appropriately be used in patients with uncontrolled symptoms and/or moderate/severe nasal obstruction. In conclusion, BANS represents a valuable option in managing patients with type 2 inflammation of the nose."

Journal • Allergic Rhinitis • Immunology • Inflammation • Nasal Polyps • Otorhinolaryngology

"Budenoside inhaler , Anttiobitocs. What good does telling them the dangers without treating it." (@todayistommorr1)

Benralizumab’s Role In Treating Gastrointestinal Eosinophilic Syndromes: A Case Report (EAACI 2022) - "He started budenoside/formoterol 160/4,5 ug daily and before exercise...He is medicated with fluticasone/vilanterol 184/22 ug, montelukast 10 mg and topical nasal budesonide 100 ug daily and without systemic steroids since June 2020. Our findings suggest that benralizumab has a potential role in treating other eosinophilic conditions. More studies with a larger number of patients with past clinical history of GI syndromes on benralizumab therapy should be carried out to better understand benralizumab’s action mechanism in intestinal mucosa and to understand its potential benefits."

Clinical • Allergy • Immunology • Inflammation • IL5

"Some merit in the early use of inhaled steriod, Budenoside. 👇 https://t.co/jaUcf4XS0z" (@doctorshaib)

"Aything fundamentally diffetent re budenoside i.e can this be replaced with another inhaled steroid, if unavailable?" (@Jay__Bernard)

Buparid/PARI SINUS Versus Budes® Nasal Spray in the Therapy of Chronic Rhinosinusitis With Polyposis Nasi (clinicaltrials.gov) - P3; N=20; Recruiting; Sponsor: Pari Pharma GmbH; Trial completion date: Jul 2015 ->Oct 2015

Trial completion date • Biosimilar